Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
8th grade Avg
|
|
New words:
abatacept, abbreviated, Additionally, adnectin, aggregate, Alpha, bevacizumab, biliary, Biogen, bleeding, blood, Book, border, breast, build, Cabometyx, cabozantinib, capability, certification, challenged, CML, committed, consultation, CRC, CytomX, database, deficient, document, Duchenne, Dystrophy, elotuzumab, embolism, enacted, entecavir, enzyme, epacadostat, equally, event, evolve, exit, formulation, fragment, gastric, GBM, GTN, HCC, HNC, imatinib, Incyte, IO, iPierian, ipilimumab, IPRD, joint, kidney, meslylate, mismatch, molecule, Muscular, network, nivolumab, offering, optimization, Orange, OTC, Palsy, pembrolizumab, percent, personnel, platform, predetermined, prejudice, prioritized, Probody, rank, recorded, redeem, reform, registered, repair, Roche, Sakigake, scale, senior, simplified, simplify, small, Southern, spectrum, speed, successfully, sulfate, Supranuclear, tract, unsecured, upheld, venture, Virginia, warfarin, West, workforce
Removed:
AbbVie, accounted, agility, alfa, alleging, amend, America, andexanet, anticoagulant, antipsychotic, applicable, approve, Arginine, arm, assessing, assessment, authority, autoimmune, awarded, begin, Benckiser, biotechnology, bipolar, BRAF, brand, Breakthrough, cell, cetuximab, chemotherapy, choice, classical, classified, colorectal, commercializing, comparable, comprising, countersued, creating, declaratory, dedicated, defend, Deiminase, demonstrated, depressive, destructive, determinable, dexamethasone, disorder, docetaxel, Dutch, earlier, EC, Efferalgan, element, Eli, EMA, employed, entrepreneurial, Erbitux, excluded, exclusively, expanding, expressed, extent, file, firm, Food, force, genetically, half, HCV, Hodgkin, Honjo, identified, II, immunodeficiency, initially, Inter, introduction, investigator, killer, Kingdom, Korea, Korman, launch, leadership, lease, legislation, lesser, leverage, lymphoma, maintained, mania, measurement, median, Medicaid, Medicinal, Member, met, methotrexate, monetary, monitoring, mutation, mutational, natural, negatively, nonvested, NSQ, opposed, ownership, PAD, Padlock, patient, permanently, platinum, plc, Portola, positive, preclinical, present, prevent, profile, programmed, promised, prospective, PTAB, pursue, rapid, reach, readily, receive, Reckitt, recognize, recommendation, referred, regimen, released, remeasurement, remedy, renal, replace, response, Revlimid, rheumatoid, schizophrenia, showed, sofosbuvir, South, spending, stem, stop, stopped, submission, submitted, sued, supporting, tiered, trademark, transferred, transition, transitional, transitioned, unfavorable, Union, unit, utility, validated, valuation, version, ViiV, wholly
Filing tables
Filing exhibits
Related press release
BMY similar filings
Filing view
External links